E2CB2former: Effecitve and Explainable Transformer for CB2 Receptor Ligand Activity Prediction
- URL: http://arxiv.org/abs/2502.12186v1
- Date: Sat, 15 Feb 2025 05:05:49 GMT
- Title: E2CB2former: Effecitve and Explainable Transformer for CB2 Receptor Ligand Activity Prediction
- Authors: Jiacheng Xie, Yingrui Ji, Linghuan Zeng, Xi Xiao, Gaofei Chen, Lijing Zhu, Joyanta Jyoti Mondal, Jiansheng Chen,
- Abstract summary: CB2former is a framework that combines a Graph Convolutional Network with a Transformer architecture to predict CB2 receptor ligand activity.<n>We benchmark CB2former against diverse baseline models and demonstrate its superior performance with an R squared of 0.685, an RMSE of 0.675, and an AUC of 0.940.<n>Our results showcase the transformative potential of advanced AI approaches exemplified by CB2former in delivering both accurate predictions and actionable molecular insights.
- Score: 11.078168240910147
- License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
- Abstract: Accurate prediction of CB2 receptor ligand activity is pivotal for advancing drug discovery targeting this receptor, which is implicated in inflammation, pain management, and neurodegenerative conditions. Although conventional machine learning and deep learning techniques have shown promise, their limited interpretability remains a significant barrier to rational drug design. In this work, we introduce CB2former, a framework that combines a Graph Convolutional Network with a Transformer architecture to predict CB2 receptor ligand activity. By leveraging the Transformer's self attention mechanism alongside the GCN's structural learning capability, CB2former not only enhances predictive performance but also offers insights into the molecular features underlying receptor activity. We benchmark CB2former against diverse baseline models including Random Forest, Support Vector Machine, K Nearest Neighbors, Gradient Boosting, Extreme Gradient Boosting, Multilayer Perceptron, Convolutional Neural Network, and Recurrent Neural Network and demonstrate its superior performance with an R squared of 0.685, an RMSE of 0.675, and an AUC of 0.940. Moreover, attention weight analysis reveals key molecular substructures influencing CB2 receptor activity, underscoring the model's potential as an interpretable AI tool for drug discovery. This ability to pinpoint critical molecular motifs can streamline virtual screening, guide lead optimization, and expedite therapeutic development. Overall, our results showcase the transformative potential of advanced AI approaches exemplified by CB2former in delivering both accurate predictions and actionable molecular insights, thus fostering interdisciplinary collaboration and innovation in drug discovery.
Related papers
- Node2Vec-DGI-EL: A Hierarchical Graph Representation Learning Model for Ingredient-Disease Association Prediction [8.749982610059874]
This study proposes an ingredient-disease association prediction model (Node2Vec-DGI-EL) based on hierarchical graph representation learning.
To improve prediction accuracy and robustness, an ensemble learning method is incorporated to achieve more accurate ingredient-disease association predictions.
arXiv Detail & Related papers (2025-05-01T01:06:05Z) - BHViT: Binarized Hybrid Vision Transformer [53.38894971164072]
Model binarization has made significant progress in enabling real-time and energy-efficient computation for convolutional neural networks (CNN)
We propose BHViT, a binarization-friendly hybrid ViT architecture and its full binarization model with the guidance of three important observations.
Our proposed algorithm achieves SOTA performance among binary ViT methods.
arXiv Detail & Related papers (2025-03-04T08:35:01Z) - scGSDR: Harnessing Gene Semantics for Single-Cell Pharmacological Profiling [5.831554646284266]
scGSDR is a model that integrates two computational pipelines grounded in the knowledge of cellular states and gene signaling pathways.<n> scGSDR enhances predictive performance by incorporating gene semantics and employs an interpretability module.<n>The model's application has extended from single-drug predictions to scenarios involving drug combinations.
arXiv Detail & Related papers (2025-02-02T15:43:20Z) - Dumpling GNN: Hybrid GNN Enables Better ADC Payload Activity Prediction Based on Chemical Structure [53.76752789814785]
DumplingGNN is a hybrid Graph Neural Network architecture specifically designed for predicting ADC payload activity based on chemical structure.
We evaluate it on a comprehensive ADC payload dataset focusing on DNA Topoisomerase I inhibitors.
It demonstrates exceptional accuracy (91.48%), sensitivity (95.08%), and specificity (97.54%) on our specialized ADC payload dataset.
arXiv Detail & Related papers (2024-09-23T17:11:04Z) - Prototype Learning Guided Hybrid Network for Breast Tumor Segmentation in DCE-MRI [58.809276442508256]
We propose a hybrid network via the combination of convolution neural network (CNN) and transformer layers.
The experimental results on private and public DCE-MRI datasets demonstrate that the proposed hybrid network superior performance than the state-of-the-art methods.
arXiv Detail & Related papers (2024-08-11T15:46:00Z) - Barlow Twins Deep Neural Network for Advanced 1D Drug-Target Interaction Prediction [0.0]
BarlowDTI uses the powerful Barlow Twins architecture for feature-extraction.
It achieves state-of-the-art predictive performance against multiple established benchmarks.
By comparing co-crystal structures, we find that BarlowDTI effectively exploits catalytically active and stabilising residues.
arXiv Detail & Related papers (2024-07-31T14:06:18Z) - Multi-objective generative AI for designing novel brain-targeting small molecules [0.20088541799100385]
We use multi-objective generative AI to synthesize drug-like BBB-permeable small molecules.
Specifically, we computationally synthesize molecules with predicted binding affinity against dopamine receptor D2.
We design a library of 26,581 novel and diverse small molecules containing hits with high predicted BBB permeability and favorable predicted safety and toxicity profiles.
arXiv Detail & Related papers (2024-04-16T12:57:06Z) - Quantum Computing-Enhanced Algorithm Unveils Novel Inhibitors for KRAS [10.732020360180773]
We introduce a quantum-classical generative model that seamlessly integrates the power of quantum algorithms trained on a 16-qubit IBM quantum computer.
Our work shows for the first time the use of a quantum-generative model to yield experimentally confirmed biological hits.
arXiv Detail & Related papers (2024-02-13T04:19:06Z) - Neural-Logic Human-Object Interaction Detection [67.4993347702353]
We present L OGIC HOI, a new HOI detector that leverages neural-logic reasoning and Transformer to infer feasible interactions between entities.
Specifically, we modify the self-attention mechanism in vanilla Transformer, enabling it to reason over the human, action, object> triplet and constitute novel interactions.
We formulate these two properties in first-order logic and ground them into continuous space to constrain the learning process of our approach, leading to improved performance and zero-shot generalization capabilities.
arXiv Detail & Related papers (2023-11-16T11:47:53Z) - Differentiable Agent-based Epidemiology [71.81552021144589]
We introduce GradABM: a scalable, differentiable design for agent-based modeling that is amenable to gradient-based learning with automatic differentiation.
GradABM can quickly simulate million-size populations in few seconds on commodity hardware, integrate with deep neural networks and ingest heterogeneous data sources.
arXiv Detail & Related papers (2022-07-20T07:32:02Z) - A Robust Backpropagation-Free Framework for Images [47.97322346441165]
We present an error kernel driven activation alignment algorithm for image data.
EKDAA accomplishes through the introduction of locally derived error transmission kernels and error maps.
Results are presented for an EKDAA trained CNN that employs a non-differentiable activation function.
arXiv Detail & Related papers (2022-06-03T21:14:10Z) - Improved Drug-target Interaction Prediction with Intermolecular Graph
Transformer [98.8319016075089]
We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture.
Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively.
IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
arXiv Detail & Related papers (2021-10-14T13:28:02Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.